Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Solid and Hematological Malignancies”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT04389541
What this trial is testing

Clinical Research Platform on Decision Making and Clinical Impact of Biomarker-Driven Precision Oncology

Who this might be right for
Advanced Solid Tumors or Hematologic Malignancies
iOMEDICO AG 499
Early research (Phase 1)UnknownNCT05549557
What this trial is testing

IMM40H Phase I Dose Escalation and Expansion

Who this might be right for
Tumor
ImmuneOnco Biopharmaceuticals (Shanghai) Inc. 16
Not applicableActive Not RecruitingNCT02041416
What this trial is testing

Technology to Assess Vulnerable Older Adults With Cancer and Their Caregivers

Who this might be right for
CancerSolid TumorHematologic Malignancy
City of Hope Medical Center 100
Early research (Phase 1)Study completedNCT01164163
What this trial is testing

INCB18424 in Treating Young Patients With Relapsed or Refractory Solid Tumor, Leukemia, or Myeloproliferative Disease

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaMyelodysplastic Syndromes+2 more
Children's Oncology Group 49
Testing effectiveness (Phase 2)Study completedNCT04333914
What this trial is testing

Prospective Study in Patients With Advanced or Metastatic Cancer and SARS-CoV-2 Infection

Who this might be right for
SARS-CoV-2 (COVID-19) InfectionAdvanced or Metastatic Hematological or Solid Tumor
Centre Leon Berard 19
Post-approval studies (Phase 4)Study completedNCT02564094
What this trial is testing

Epoetin Beta (NeoRecormon) in Participants With Solid Tumors or Hematologic Malignancies

Who this might be right for
Anemia
Hoffmann-La Roche 54
Early research (Phase 1)Study completedNCT04419623
What this trial is testing

TL-895 With Standard Available Treatment Versus Standard Available Treatment for the Treatment of COVID-19 in Patients With Cancer

Who this might be right for
COVID-19Sars-CoV2Cancer+3 more
Telios Pharma, Inc. 7
Not applicableLooking for participantsNCT04678427
What this trial is testing

Exercise Program (TEAM Me) for the Improvement of Movement and Mobility in Pediatric and Adolescent and Young Adult Patients With Cancer Undergoing a Blood Stem Cell Transplant

Who this might be right for
Hematopoietic and Lymphoid Cell NeoplasmMalignant Solid Neoplasm
M.D. Anderson Cancer Center 60
Not applicableActive Not RecruitingNCT04875286
What this trial is testing

Patient Reported Symptom Control With THC or CBD Use

Who this might be right for
Cancer-Associated PainHematopoietic and Lymphoid Cell NeoplasmMalignant Solid Neoplasm
M.D. Anderson Cancer Center 200
Not applicableActive Not RecruitingNCT04743466
What this trial is testing

Evaluation of Association Between Testosterone Levels, Dementia, and Adverse Mental Health Outcomes

Who this might be right for
Anxiety DisorderDepressionGenetic Disorder+2 more
M.D. Anderson Cancer Center 1
Testing effectiveness (Phase 2)Ended earlyNCT02465528
What this trial is testing

Ceritinib Rare Indications Study in ALK+ Tumors

Who this might be right for
Tumors With Aberrations in ALKAnaplastic Large Cell LymphomaInflammatory Myofibroblastic Tumor+1 more
Novartis Pharmaceuticals 22
Not applicableUnknownNCT04776005
What this trial is testing

COVID-19 Vaccine Efficacy in Patients With Malignant Pathologies

Who this might be right for
Solid TumorHematologic MalignancyThoracic Cancer+2 more
Assistance Publique - Hôpitaux de Paris 500
Not applicableLooking for participantsNCT02457962
What this trial is testing

Mayo Clinic Radiotherapy Patient Outcomes Registry and Biobanking Study

Who this might be right for
Solid TumorsHematologic Malignancies
Mayo Clinic 15,000
Not applicableStudy completedNCT05036408
What this trial is testing

Cancer Pain Rehabilitation Program to Reduce Pain Related Distress, and Reliance of Pain Medication Through Multimodal Nonpharmacological Solutions

Who this might be right for
Hematopoietic and Lymphoid Cell NeoplasmMalignant Solid Neoplasm
City of Hope Medical Center 16
Testing effectiveness (Phase 2)Study completedNCT00823524
What this trial is testing

Donor Natural Killer Cells After Donor Stem Cell Transplant in Treating Patients With Advanced Cancer

Who this might be right for
Brain and Central Nervous System TumorsChronic Myeloproliferative DisordersLeukemia+6 more
Asan Medical Center 47
Large-scale testing (Phase 3)Study completedNCT00003687
What this trial is testing

Treatment for Chronic Pain in Patients With Advanced Cancer

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+6 more
NCIC Clinical Trials Group 87
Not applicableEnded earlyNCT06566209
What this trial is testing

FDG-PET as an Imaging Modality to Diagnose and Risk Stratify Subclinical, Imaging Negative Ici-Myocarditis

Who this might be right for
Subclinical Immune Checkpoint Inhibitor-Induced MyocarditisMyocarditisICI-Myocarditis+4 more
Mayo Clinic 2
Large-scale testing (Phase 3)Looking for participantsNCT05770544
What this trial is testing

DETERMINE Trial Treatment Arm 03: Entrectinib in Adult, Paediatric and Teenage/Young Adult Patients With ROS1 Gene Fusion-Positive Cancers.

Who this might be right for
Haematological MalignancyMalignancyMalignant Neoplasm+8 more
Cancer Research UK 30
Testing effectiveness (Phase 2)Ended earlyNCT02186821
What this trial is testing

Ceritinib (LDK378) for Patients Whose Tumors Have Aberrations in ALK or ROS1 (SIGNATURE)

Who this might be right for
Tumors With Aberrations in ALK or ROS1
Novartis Pharmaceuticals 47
Early research (Phase 1)Study completedNCT00025415
What this trial is testing

Imatinib Mesylate in Treating Patients With Advanced Cancer and Liver Dysfunction

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAcute Undifferentiated LeukemiaAIDS-related Peripheral/Systemic Lymphoma+78 more
National Cancer Institute (NCI) 60
Next Page